Rinderpest virus sequestration and use in posteradication era
Related Experiment Video
Updated: May 15, 2026

09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Guillaume Fournié1, Wendy Beauvais, Bryony A Jones
1Royal Veterinary College, London, UK. gfournie@rvc.ac.uk
Emerging Infectious Diseases
|December 25, 2012
Abstract:
After the 2011 declaration of rinderpest disease eradication, we surveyed 150 countries about rinderpest virus stocks. Forty-four laboratories in 35 countries held laboratory-attenuated strains, field strains, or diagnostic samples. Vaccine and reagent production and laboratory experiments continued. Rigorous standards are necessary to ensure that stocks are kept under safe conditions.

